Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Charles Wagner, Jr., Stephen Jones, Thomas Kean, Melinda Griffith, and More

Premium

GoodStart Genetics has appointed Charles Wagner, Jr., to its board of directors. Wagner is CFO and executive VP of finance and administration at Bruker Corporation. Previously, he held similar positions at Progress Software Corporatio and Millipore Corporation.


MolecularHealth has added several new members to its advisory board, including Stephen Jones, who from 1999 to 2014 served as the medical director of research for US Oncology Research; Thomas Kean, CEO and president of C-Change, a coalition of stakeholders dedicated to eliminating the cancer burden on the US population; and Kathleen Lokay, president and CEO of Via Oncology.


CardioDx announced that Melinda Griffith will be its new head of corporate development and general counsel and Doug Ross will the firm's new chief scientific officer. Griffith has previously held various executive management positions at Clarient, which was acquired by GE Healthcare. Ross served as acting chief scientific officer of Life Technologies' medical science division.

Simultaneously, CardioDx also appointed James Tobin and Andrew Guggenhime to its board of directors. Tobin was previously CEO of Boston Scientific. Meanwhile, Guggenhime is transitioning currently from his role as CFO at CardioDx to its board of directors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.